These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 11937308

  • 1. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma.
    Tot T.
    Eur J Cancer; 2002 Apr; 38(6):758-63. PubMed ID: 11937308
    [Abstract] [Full Text] [Related]

  • 2. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
    Tot T.
    Cancer; 2001 Nov 15; 92(10):2727-32. PubMed ID: 11745209
    [Abstract] [Full Text] [Related]

  • 3. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH, Mullink H, Van Diest PJ, Meijer GA, Meijer CJ.
    Hum Pathol; 1998 May 15; 29(5):491-7. PubMed ID: 9596273
    [Abstract] [Full Text] [Related]

  • 4. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
    Shah RN, Badve S, Papreddy K, Schindler S, Laskin WB, Yeldandi AV.
    Hum Pathol; 2002 Sep 15; 33(9):915-20. PubMed ID: 12378517
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.
    Cancer; 2001 Oct 25; 93(5):330-6. PubMed ID: 11668468
    [Abstract] [Full Text] [Related]

  • 7. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM, Lin DM, Lü N, Liu XY, Wen P, Liu FS.
    Zhonghua Yi Xue Za Zhi; 2003 Aug 10; 83(15):1350-2. PubMed ID: 12930693
    [Abstract] [Full Text] [Related]

  • 8. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis.
    Tot T, Samii S.
    APMIS; 2003 Dec 10; 111(12):1075-82. PubMed ID: 14678015
    [Abstract] [Full Text] [Related]

  • 9. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY, Kim HS, Hong EK, Kim WH.
    Hum Pathol; 2002 Nov 10; 33(11):1078-85. PubMed ID: 12454811
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions.
    Jang KY, Kang MJ, Lee DG, Chung MJ.
    Anal Quant Cytol Histol; 2001 Dec 10; 23(6):400-4. PubMed ID: 11777274
    [Abstract] [Full Text] [Related]

  • 12. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases].
    Fernandez C, Liprandi A, Bouvier-Labit C, Figarella-Branger D.
    Ann Pathol; 2001 Apr 10; 21(2):129-35. PubMed ID: 11373582
    [Abstract] [Full Text] [Related]

  • 13. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
    Tot T.
    Cancer; 1999 Jan 01; 85(1):171-7. PubMed ID: 9921990
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
    Dai L, Song Q, Li L, Zhong D, Hui Y.
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr 01; 30(2):114-7. PubMed ID: 11866966
    [Abstract] [Full Text] [Related]

  • 16. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM, Meir A, Sabo E.
    Int J Gynecol Pathol; 2004 Jan 01; 23(1):52-7. PubMed ID: 14668551
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
    Vang R, Gown AM, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM.
    Am J Surg Pathol; 2006 Sep 01; 30(9):1130-9. PubMed ID: 16931958
    [Abstract] [Full Text] [Related]

  • 19. Cytokeratin 7 and 20 as immunohistochemical markers in identification of primary tumors in craniospinal metastases: do they have a significant role?
    Taweevisit M, Isarakul P, Chaipipat M, Keetacheeva K, Wattanasirmkit V, Shuangshoti S.
    Neuropathology; 2003 Dec 01; 23(4):271-4. PubMed ID: 14719541
    [Abstract] [Full Text] [Related]

  • 20. Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract.
    Kende AI, Carr NJ, Sobin LH.
    Histopathology; 2003 Feb 01; 42(2):137-40. PubMed ID: 12558745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.